There is lack of monitoring from the injury site to guide management of patients with acute traumatic spinal cord injury. Here we describe a bedside microdialysis monitoring technique for optimizing spinal cord perfusion and drug delivery at the injury site.
INTRODUCTION
Traumatic spinal cord injury (TSCI) is a devastating condition that, each year, affects about 15 -40 people per million 1 . The surgical, anesthetic and neurointensive care unit management of patients with acute TSCI is variable 2, 3 . To guide management, we recently developed a novel technique to continuously monitor intraspinal pressure (ISP) at the injury site and compute spinal cord perfusion pressure (SCPP) 4, 5 . Intraoperatively, a pressure probe is inserted subdurally to measure ISP at the injury site, which is the same as intraparenchymal ISP 6 . Monitoring ISP and SCPP for up to a week is safe based on a review of 42 patients 7 .
Data obtained from human 8, 9 and mouse 10 studies show that, after TSCI, the injured spinal cord swells and becomes compressed against the dura. Three intradural compartments form (above, at and below the injury site) each with a different ISP 11 . The low SCPP at the injury site 5, 8 suggests that the injured spinal cord is ischemic. We showed that SCPP can be increased by increasing the mean arterial pressure with inotropes 5 or by reducing ISP with expansion duroplasty 8 . It remains unclear whether increasing SCPP is beneficial for the injured spinal cord.
Microdialysis is widely used to monitor brain metabolism in brain-injured patients 12 .
Microdialysis catheters monitor hourly the levels of brain tissue glucose, lactate, pyruvate, glutamate and glycerol in the extracellular space. Low glucose, high lactate, high lactate-topyruvate ratio (LPR) and high lactate-to-glucose ratio (LGR) indicate metabolic derangement [13] [14] [15] . Glutamate is released during ischemia and causes neuronal death (excitotoxicity) whereas glycerol is a marker for cell membrane lipid degradation 12 .
Microdialysis has also been used to quantify penetration of drugs including vigabatrin 16 , metronidazole 17 and cefotaxime 18 into injured human brain. Microdialysis monitoring has not previously been used in TSCI patients. Here, we describe a simple technique for simultaneous bedside monitoring of SCPP and microdialysis at the injury site. This technique 4 was used to determine the SCPP and tissue glucose level that minimize the metabolic derangement at the injury site; these are termed the optimal SCPP and the optimal tissue glucose level, respectively. We also determined the effect of altering SCPP on the entry of intravenously administered drugs into the damaged spinal cord. which has a 3 cm long membrane, long shaft and 20 kDa cut-off rather than the CMA70 or CMA71 brain catheters, which are too short to tunnel for spinal cord monitoring. Details of the CMA61 catheter are in the Supplement. Under the operating microscope, the dura and arachnoid membranes were opened one level below the injury (Fig. 1A) Metabolite recovery. The extrapolation to zero flow method was used to determine metabolite recoveries 19 . Data were collected on the last day of monitoring when metabolite levels were stable. Flow rate was changed every 2 hours and samples were collected every 30
MATERIALS AND METHODS
minutes. The first sample of each 2-hour period was discarded to allow for the transit time of the microdialysis fluid from the exchange membrane to the vial. We used flow rates of 0.3, Dexamethasone assay. In three TSCI patients, a bolus of 4 mg dexamethasone was given intravenously. Venous blood was withdrawn before giving dexamethasone (0 min) and at 10 
RESULTS
Patient details. We recruited 14 consecutively admitted TSCI patients with mean age 38 years (Table 1) . After surgery, patients were kept in the neurointensive care unit throughout the monitoring period. Most (92.9 %) were male, most (57.1 %) had thoracic injuries and For each metabolite, there was excellent goodness-of-fit (r < -0.95) with the theoretical curve.
Relative recoveries were calculated from the theoretical curves as the metabolite concentration at 0.3 µL/min divided by the estimated metabolite concentration at no flow.
Our data indicate relative recoveries at 88 -100 % (Fig. 1D) .
SCPP vs. metabolite levels. During the microdialysis monitoring period the average SCPP of all patients was 60 -80 mmHg ( Fig. 2A) LGR and positive correlation between SCPP vs. glucose. SCPP > 100 mmHg was associated with more deranged metabolism at the injury site than SCPP 90 -100 mmHg, i.e. higher glutamate, lower glucose, higher LPR and higher LGR. Glycerol concentration was high (~55 mM) with SCPP below 60 -70 mmHg and low (~40 mmM) with SCPP > 70 mmHg. There was no correlation between average daily metabolite concentrations, LPR or LGR at the 
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injury site vs. ISP (not shown). We also plotted tissue glucose concentration at the injury site vs. LPR (Fig. 2F) . Tissue glucose concentration >4.5 mM was associated with the lowest LPR; below 4.5 mM, glucose concentration inversely correlated with LPR. Glucose concentration at the injury site was 35.5 ± 1.0 % of serum glucose. Fig. 2G shows the relationship between serum glucose and microdialysis glucose. The data suggest that, after TSCI, optimum SCPP is 90 -100 mmHg and optimum tissue glucose is >4.5 mM.
Metabolites in complete vs. incomplete injuries. In Fig. 3 we compare average daily 
best-fit exponential decay curve was -1.00 for high and low SCPP (Fig. 4B) vs. 6 ng.h/mL and peak spinal cord concentration at 4.8 vs. 2.0 ng/mL (Fig. 4C) . Only a small proportion of the intravenous dexamethasone entered the spinal cord with AUC 0-8h(cord) /AUC 0-8h(serum) = 1.62 vs. 0.64 % at high vs. low SCPP. Therefore, increasing SCPP markedly increases the entry of dexamethasone from the blood into the injured spinal cord.
Complications. Table 2 
DISCUSSION
We showed that, in patients with acute TSCI, simultaneous monitoring of SCPP and microdialysis from the injury site is feasible and safe. The microdialysis catheter was easily 
Annals of Neurology
inserted during spinal fixation surgery and was removed in the neurointensive care unit.
Complications related to the microdialysis catheter were minor; they include CSF leak from the catheter exit site that resolved by suturing the skin and asymptomatic pseudomeningocele that resolved spontaneously. Since our patient sample is small, complications may appear in a larger sample. Our microdialysis data suggest that the optimal SCPP is 90 -100 mmHg and the optimal tissue glucose is more than 4.5 mM because these values minimize the metabolic derangement at the injury site. We also showed that simultaneous monitoring of SCPP and microdialysis could be used to enhance drug entry at the injury site. Based on our current findings and earlier studies [4] [5] [6] [7] [8] [9] 20, 21 , a large-scale study of outcome from TSCI in patients who have monitoring vs. those who do not is warranted.
There are technical nuances. First, a long (3 cm) exchange membrane was inserted to achieve near complete metabolite recovery at 0.3 µL/min flow rate, compared with a 1 cm long microdialysis membrane at 0.3 µL/min, which only achieves 70 % metabolite recovery 22 . Second, we placed the microdialysis catheter under the arachnoid because diffusion across the arachnoid is limited by inter-cellular tight junctions 23 and is greatly reduced for hydrophilic substances 24 . Third, we used surface rather than intraparenchymal microdialysis. Surface microdialysis was originally described in pig liver 25 and myocardium 26 with excellent correlations between surface and intraparenchymal levels of lactate, glucose and glycerol. We advocate using surface rather than intraparenchymal microdialysis monitoring to minimize the risk of probe-related hematoma and mechanical spinal cord damage.
We found more profound metabolic derangement in AIS A than AIS B/C patients.
These findings suggest that the severity of TSCI correlates with the metabolic derangement at the injury site. A microdialysis study in a pig TSCI model concluded that the metabolic response at the injury site depends on the biomechanical nature of the injury 27 . Further 
studies are required to determine if the metabolic derangement at the injury site accurately predicts AIS grade conversion after TSCI.
Microdialysis was used to characterize the relationship between SCPP, ISP, glucose and metabolism at the injury site. SCPP pressure below 70 mmHg was associated with cell lysis (high glycerol). As SCPP increased to 90 -100 mmHg, metabolism improved (lower glutamate and lactate, lower LPR and LGR and higher glucose). Interestingly, when SCPP increased above 100 mmHg the metabolic profile worsened (higher glutamate and lactate, higher LPR and LGR and lower glucose). Therefore, not only hypoperfusion (SCPP below 90 mmHg), but also hyperperfusion (SCPP above 100 mmHg) may be detrimental for the injured spinal cord. This is consistent with our earlier report of a U-shaped relationship between the spinal pressure reactivity index and SCPP, which also indicated optimum SCPP around 90 mmHg 5, 8, 21 . We conclude that multi-modality monitoring from the injury site after TSCI is helpful for guiding clinical management to reduce secondary damage. Further studies are needed to determine if interventions to optimize SCPP and tissue metabolite levels improve outcome. 
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